DiscGenics Announces Positive Two-Year Clinical Data from St

/PRNewswire/ -- DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and...

Related Keywords

Matthewf Gornet , Flagg Flanagan , Us Food Drug Administration , Discgenics Inc , Drug Administration , Orthopedic Center , Office Of Tissues , Visual Analog Scale , Minimal Clinically Important Difference , Board Certified Spine Surgeon , Oswestry Disability Index Questionnaire , Chief Executive Officer , Advanced Therapies , Drug Substance , Discogenic Cells , Sodium Hyaluronate Solution , Final Drug , Fast Track , Chronic Low Back Pain , Degenerative Disc , Discgenics , Nc , Biotechnology , Medical Pharmaceuticals , Health Care Amp Hospitals , Surveys , Olls And Research , Clinical Trials Amp Medical Discoveries ,